| Publication | Date of Publication | Type |
|---|
Two-stage designs for cross-over bioequivalence trials
Statistics in Medicine | 2025-11-10 | Paper |
Opportunities and challenges of combined effect measures based on prioritized outcomes
Statistics in Medicine | 2025-09-12 | Paper |
Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework
Statistics in Medicine | 2025-07-08 | Paper |
A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance
Statistics in Medicine | 2025-02-07 | Paper |
Sample size calculation under nonproportional hazards using average hazard ratios
Biometrical Journal | 2024-12-05 | Paper |
Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials
Statistics in Medicine | 2024-10-30 | Paper |
A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation
Statistics in Medicine | 2024-10-29 | Paper |
Selection of variables for multivariable models: opportunities and limitations in quantifying model stability by resampling
Statistics in Medicine | 2024-10-29 | Paper |
Optimal planning of adaptive two-stage designs
Statistics in Medicine | 2024-10-29 | Paper |
A variational approach to optimal two-stage designs
Statistics in Medicine | 2024-10-28 | Paper |
What makes a biostatistician?
Statistics in Medicine | 2024-10-28 | Paper |
Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints
Statistics in Medicine | 2024-10-14 | Paper |
Optimization of adaptive designs with respect to a performance score
Biometrical Journal | 2023-12-15 | Paper |
Optimization of the two‐stage group sequential three‐arm gold‐standard design for non‐inferiority trials
Statistics in Medicine | 2022-12-28 | Paper |
| A comprehensive survey among statistical members of medical ethics committees in Germany on their personal impression of completeness and correctness of biostatistical aspects of submitted study protocols | 2021-09-30 | Dataset |
Optimal planning of adaptive two‐stage designs
Statistics in Medicine | 2021-03-18 | Paper |
The adoptr Package: Adaptive Optimal Designs for Clinical Trials in R
Journal of Statistical Software | 2021-01-01 | Paper |
| Unvalidated R source code | 2019-11-25 | Dataset |
A variational approach to optimal two‐stage designs
Statistics in Medicine | 2019-07-01 | Paper |
Consistency-adjusted alpha allocation methods for a time-to-event analysis of composite endpoints
Computational Statistics and Data Analysis | 2018-11-23 | Paper |
W. Q.Meeker, G. J.Hahn, L. A.Escobar. Statistical Intervals—A Guide for Practitioners and Researchers. (2017) Hoboken, NJ: John Wiley & Sons., 648 pages, ISBN 978‐0‐471‐68717‐7
Biometrical Journal | 2018-11-05 | Paper |
An expected power approach for the assessment of composite endpoints and their components
Computational Statistics and Data Analysis | 2017-06-30 | Paper |
Randomised Response-Adaptive Designs in Clinical Trials. A. C. Atkinson and A. Biswas (2014). Boca Raton: CRC Press, Taylor and Francis Group. 323 pages, ISBN 978-1-58488-693-8.
Biometrical Journal | 2014-11-21 | Paper |
| The LORELIA residual test. A new outlier identification test for method comparison studies. With CD-ROM | 2010-08-19 | Paper |
